Skip to main content
NCBI home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2000 Jul-Aug;6(4):348–357. doi: 10.3201/eid0604.000404

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.

H E de Melker 1, J F Schellekens 1, S E Neppelenbroek 1, F R Mooi 1, H C Rümke 1, M A Conyn-van Spaendonck 1
PMCID: PMC2640897  PMID: 10905967

Abstract

We analyzed pertussis reporting, death, hospitalization, and serodiagnostic data from 1976 to 1998 to help explain the cause of the 1996 pertussis outbreak in the Netherlands. The unexpected outbreak was detected by an increase in pertussis reporting and by other surveillance methods. In 1996, according to reporting and serologic data, the increase in pertussis incidence among (mostly unvaccinated) children less than 1 year of age was similar to the increase in hospital admissions. Among older (mostly vaccinated) persons, the increase in hospital admissions was relatively small. The increase in pertussis incidence was higher among vaccinated than among unvaccinated persons of all ages. This resulted in lower estimates of vaccine effectiveness. The proportion of pertussis infections resulting in recognizable symptoms may have increased among vaccinated persons because of a mismatch of the vaccine strain and circulating Bordetella pertussis strains. The small immunogenicity profile of the Dutch vaccine may have resulted in greater vulnerability to antigenic changes in B. pertussis.

Full Text

The Full Text of this article is available as a PDF (103.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews R., Herceg A., Roberts C. Pertussis notifications in Australia, 1991 to 1997. Commun Dis Intell. 1997 May 29;21(11):145–148. doi: 10.33321/cdi.1997.21.30. [DOI] [PubMed] [Google Scholar]
  2. Baker J. D., Halperin S. A., Edwards K., Miller B., Decker M., Stephens D. Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines. J Pediatr. 1992 Oct;121(4):523–527. doi: 10.1016/s0022-3476(05)81138-2. [DOI] [PubMed] [Google Scholar]
  3. Bass J. W., Stephenson S. R. The return of pertussis. Pediatr Infect Dis J. 1987 Feb;6(2):141–144. doi: 10.1097/00006454-198702000-00001. [DOI] [PubMed] [Google Scholar]
  4. Bass J. W., Wittler R. R. Return of epidemic pertussis in the United States. Pediatr Infect Dis J. 1994 May;13(5):343–345. doi: 10.1097/00006454-199405000-00002. [DOI] [PubMed] [Google Scholar]
  5. Bentsi-Enchill A. D., Halperin S. A., Scott J., MacIsaac K., Duclos P. Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population. Vaccine. 1997 Feb;15(3):301–306. doi: 10.1016/s0264-410x(96)00176-4. [DOI] [PubMed] [Google Scholar]
  6. De Serres G., Boulianne N., Douville Fradet M., Duval B. Pertussis in Quebec: ongoing epidemic since the late 1980s. Can Commun Dis Rep. 1995 Mar 15;21(5):45–48. [PubMed] [Google Scholar]
  7. Farrington C. P. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol. 1993 Aug;22(4):742–746. doi: 10.1093/ije/22.4.742. [DOI] [PubMed] [Google Scholar]
  8. Guris D., Strebel P. M., Tachdjian R., Bardenheier B., Wharton M., Hadler S. C. Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States, 1992-1994. J Infect Dis. 1997 Aug;176(2):456–463. doi: 10.1086/514064. [DOI] [PubMed] [Google Scholar]
  9. Güriş D., Strebel P. M., Bardenheier B., Brennan M., Tachdjian R., Finch E., Wharton M., Livengood J. R. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis. 1999 Jun;28(6):1230–1237. doi: 10.1086/514776. [DOI] [PubMed] [Google Scholar]
  10. Isacson J., Trollfors B., Taranger J., Zackrisson G., Lagergård T. How common is whooping cough in a nonvaccinating country? Pediatr Infect Dis J. 1993 Apr;12(4):284–288. doi: 10.1097/00006454-199304000-00005. [DOI] [PubMed] [Google Scholar]
  11. Mastrantonio P., Spigaglia P., van Oirschot H., van der Heide H. G., Heuvelman K., Stefanelli P., Mooi F. R. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology. 1999 Aug;145(Pt 8):2069–2075. doi: 10.1099/13500872-145-8-2069. [DOI] [PubMed] [Google Scholar]
  12. Milord F. Resurgence of pertussis in Montérégie, Quebec--1990-1994. Can Commun Dis Rep. 1995 Mar 15;21(5):40–44. [PubMed] [Google Scholar]
  13. Mooi F. R., He Q., van Oirschot H., Mertsola J. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun. 1999 Jun;67(6):3133–3134. doi: 10.1128/iai.67.6.3133-3134.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mooi F. R., van Oirschot H., Heuvelman K., van der Heide H. G., Gaastra W., Willems R. J. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun. 1998 Feb;66(2):670–675. doi: 10.1128/iai.66.2.670-675.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nagel J., Poot-Scholtens E. J. Serum IgA antibody to Bordetella pertussis as an indicator of infection. J Med Microbiol. 1983 Nov;16(4):417–426. doi: 10.1099/00222615-16-4-417. [DOI] [PubMed] [Google Scholar]
  16. Nagel J., de Graaf S., Schijf-Evers D. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels. Dev Biol Stand. 1985;61:325–330. [PubMed] [Google Scholar]
  17. Ramsay M. E., Farrington C. P., Miller E. Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods. Epidemiol Infect. 1993 Aug;111(1):41–48. doi: 10.1017/s095026880005665x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. de Melker H. E., Conyn-van Spaendonck M. A., Rümke H. C., van Wijngaarden J. K., Mooi F. R., Schellekens J. F. Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis. 1997 Apr-Jun;3(2):175–178. doi: 10.3201/eid0302.970211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. de Melker H. E., Versteegh F. G., Conyn-Van Spaendonck M. A., Elvers L. H., Berbers G. A., van Der Zee A., Schellekens J. F. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol. 2000 Feb;38(2):800–806. doi: 10.1128/jcm.38.2.800-806.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. van de Water H. P. Kinkhoestaangiften in Nederland in de periode 1976-1986 en de noodzaak van een uniforme ziektedefinitie. Ned Tijdschr Geneeskd. 1988 Apr 30;132(18):821–828. [PubMed] [Google Scholar]
  21. van de Water H. P., van de Laar M. J., Leentvaar-Kuijpers A. Wanneer is het kinkhoest? Verband tussen laboratoriumdiagnostische bevindingen en klachten. Ned Tijdschr Geneeskd. 1988 Apr 30;132(18):828–833. [PubMed] [Google Scholar]
  22. van der Zee A., Agterberg C., Peeters M., Mooi F., Schellekens J. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J Infect Dis. 1996 Jul;174(1):89–96. doi: 10.1093/infdis/174.1.89. [DOI] [PubMed] [Google Scholar]
  23. van der Zee A., Vernooij S., Peeters M., van Embden J., Mooi F. R. Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution. Microbiology. 1996 Dec;142(Pt 12):3479–3485. doi: 10.1099/13500872-142-12-3479. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES